Cancer-Fighting virus tested in patients with Tough-to-Treat colon cancer
NCT ID NCT05733611
Summary
This study tested a new combination treatment for advanced colorectal cancer that had stopped responding to standard therapies. It involved injecting a genetically engineered virus directly into tumors, along with two other drugs (atezolizumab and bevacizumab), to try to kill cancer cells and boost the immune system's attack. The trial was terminated early after enrolling only 5 participants, so its effectiveness remains unknown.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY METASTATIC COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
USC Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
University of Washington Seattle Cancer Care Alliance
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.